Literature DB >> 3806693

Syndrome of galactorrhea, amenorrhea, and obesity as possible indicators of prolactinoma: a case study approach.

B Shaw, L Creary, V Rao.   

Abstract

Four female patients were found to have microadenomas and high prolactin levels, but the symptoms of the syndrome varied among the patients. Three of four patients had overt galactorrhea, obesity, and amenorrhea. One patient was postmenopausal, and another showed menstrual irregularities. Two patients sought medical attention for headaches, and one for visual disturbances. Two patients previously had used psychotropic drugs, and two patients used birth control pills. When tested, all patients had high serum prolactin levels, abnormal sellar tomograms, and the presence of microadenoma of the pituitary was confirmed by computerized tomography.Because of the high incidence of pituitary tumor among these four patients, this study suggests that a complete workup should be done for patients having galactorrhea, amenorrhea, and obesity as a syndrome or as separate entities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3806693      PMCID: PMC2571402     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  6 in total

1.  Subclinical Adenoma of the Pituitary Gland.

Authors:  R T Costello
Journal:  Am J Pathol       Date:  1936-03       Impact factor: 4.307

Review 2.  Diagnosis and treatment of hyperprolactinemic syndromes.

Authors:  R E Blackwell
Journal:  Obstet Gynecol Annu       Date:  1985

3.  [Prolactinoma: surgical aspects].

Authors:  J Hardy; G Mohr
Journal:  Neurochirurgie       Date:  1981       Impact factor: 1.553

4.  Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series.

Authors:  G N Burrow; G Wortzman; N B Rewcastle; R C Holgate; K Kovacs
Journal:  N Engl J Med       Date:  1981-01-15       Impact factor: 91.245

Review 5.  Drugs five years later. Bromocriptine.

Authors:  M L Vance; W S Evans; M O Thorner
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

6.  Oral contraceptive use and the occurrence of pituitary prolactinoma.

Authors:  K K Shy; A M McTiernan; J R Daling; N S Weiss
Journal:  JAMA       Date:  1983 Apr 22-29       Impact factor: 56.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.